cisplatin

Open Access
Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial
TAKASHI YOSHIOKA, MASANOBU TAKAHASHI, YASUHIRO SAKAMOTO, AKIRA OKITA, TADAHISA FUKUI, YASUKO MURAKAWA, YOSHIAKI SHINDO, HIROO IMAI, HISATSUGU OHORI, HIDEKAZU SHIROTA, NATSUKO CHIBA, YURIKO (ITO) SASAHARA, TAKASHI NOMURA, NORIMASA FUKUSHIMA, TAKUHIRO YAMAGUCHI, HIDEKI SHIMODAIRA and CHIKASHI ISHIOKA

Anticancer Research April 2022, 42 (4) 2009-2015; DOI: https://doi.org/10.21873/anticanres.15680
You have access
Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells
SAE HAMAYA, SHINTARO FUJIHARA, HISAKAZU IWAMA, KOJI FUJITA, TINGTING SHI, RYOTA NAKABAYASHI, TAKAAKI MIZUO, KEI TAKUMA, MAI NAKAHARA, KYOKO OURA, TOMOKO TADOKORO, SHIMA MIMURA, JOJI TANI, ASAHIRO MORISHITA, HIDEKI KOBARA, MASAFUMI ONO, TAKASHI HIMOTO and TSUTOMU MASAKI

Anticancer Research March 2022, 42 (3) 1263-1275; DOI: https://doi.org/10.21873/anticanres.15593
You have access
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes Versus 60 Minutes After Cytoreductive Surgery (CRS). Does the 30-Minute Difference Matter? A Comparative Study in a High Volume Centre
MIKLOS ACS, LASZLO HALMY, SABINA ISGANDAROVA, SEBASTIAN BLAJ, MICHAEL GERKEN, BERNHARD HORMANN and POMPILIU PISO

Anticancer Research February 2022, 42 (2) 1019-1029; DOI: https://doi.org/10.21873/anticanres.15563
You have access
Sequence of CX-4945 and Cisplatin Administration Determines the Effectiveness of Drug Combination and Cellular Response in Cholangiocarcinoma Cells In Vitro
JOMNARONG LERTSUWAN, ANYAPORN SAWASDICHAI, NATHAPOL TASNAWIJITWONG, KEVIN GASTON, PADMA-SHEELA JAYARAMAN and JUTAMAAD SATAYAVIVAD

Anticancer Research December 2021, 41 (12) 6155-6167; DOI: https://doi.org/10.21873/anticanres.15435
You have access
Inhibition of AKT Enhances the Sensitivity of NSCLC Cells to Metformin
SE-KYEONG JANG, SUNG-EUN HONG, DA-HEE LEE, JI YEA KIM, JI-YOUNG KIM, JUNGIL HONG, IN-CHUL PARK and HYEON-OK JIN

Anticancer Research July 2021, 41 (7) 3481-3487; DOI: https://doi.org/10.21873/anticanres.15135
You have access
Total Mesometrial Resection With (Neo)Adjuvant Chemotherapy in Locally Advanced Cervical Cancer: A Tumor Response Score
MATTHIAS KIESEL, STEPHANIE SAUER, SANJA LÖB, SASKIA L. HERBERT, ACHIM WÖCKEL and CHRISTINE WULFF

Anticancer Research July 2021, 41 (7) 3543-3560; DOI: https://doi.org/10.21873/anticanres.15142
You have access
The INCH Trial – Induction Chemotherapy in Patients With Bulky Anal Canal Cancer: Evaluation of the Pilot Phase
FRANCESCA DE FELICE, ALESSIA FALLARINO, FRANCO IAFRATE, VERONICA MAIURI, GIOVANNI GALLONI, GIOVANNI TURRIZIANI COLONNA, RAFFAELLA DE PIETRO, GIUSEPPINA CHIARELLO, CLAUDIA MARCHETTI, NADIA BULZONETTI, DANIELA MUSIO and VINCENZO TOMBOLINI

Anticancer Research June 2021, 41 (6) 3187-3191; DOI: https://doi.org/10.21873/anticanres.15105
Open Access
The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line
AYAKO OGO, SACHI MIYAKE, HISAKO KUBOTA, MASAHARU HIGASHIDA, HIDEO MATSUMOTO, FUSAKO TERAMOTO, TOSHIHIRO HIRAI and TOMIO UENO

Anticancer Research April 2021, 41 (4) 1771-1778; DOI: https://doi.org/10.21873/anticanres.14942
Open Access
Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer
MOTOYUKI SUZUKI, YUKINORI TAKENAKA, TOSHIHIRO KISHIKAWA, YOSHIFUMI YAMAMOTO, ATSUSHI HANAMOTO, YOICHIRO TOMIYAMA, TAKAHITO FUKUSUMI, TAKAHIRO MICHIBA, NORIHIKO TAKEMOTO, SUSUMU NAKAHARA and HIDENORI INOHARA

Anticancer Research April 2021, 41 (4) 2045-2051; DOI: https://doi.org/10.21873/anticanres.14973
You have access
Acute Kidney Injury Following Hyperthermic Intraperitoneal Chemotherapy With Cisplatin
KERRY L. CHEN, RAPHAEL SHAMAVONIAN, JOSH B. KARPES, NAYEF A. ALZAHRANI and DAVID L. MORRIS

Anticancer Research March 2021, 41 (3) 1641-1646; DOI: https://doi.org/10.21873/anticanres.14926

Main menu

User menu

Search

cisplatin

Pages